Skip to main content

Using Design to Connect Patients, Providers, and Researchers: A Cognitive Assessment and Monitoring Platform for Integrative Research (CAMPFIRE)

  • Conference paper
  • First Online:
Advances in Human Factors and Ergonomics in Healthcare and Medical Devices (AHFE 2018)

Part of the book series: Advances in Intelligent Systems and Computing ((AISC,volume 779))

Included in the following conference series:

  • 902 Accesses

Abstract

There is a substantial need for an accessible suite of cognitive measures to assess and monitor signs of chemotherapy-related cognitive impairment during the treatment and survivorship phases of the cancer control continuum. To address this need we designed and demonstrated a Cognitive Assessment and Monitoring Platform for Integrative Research (CAMPFIRE), a privacy-compliant software system to support the administration of cognitive assessment measures and facilitate secure provider-patient interaction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. American Cancer Society: Cancer Facts & Figures 2016. American Cancer Society, Atlanta (2016)

    Google Scholar 

  2. American Cancer Society: Cancer Treatment and Survivorship Facts & Figures 2014–2015. American Cancer Society, Atlanta (2014)

    Google Scholar 

  3. Ahles, T.A., Root, J.C., Ryan, E.L.: Cancer - and cancer treatment-associated cognitive change: an update on the state of the science. J. Clin. Oncol. 30(30), 3675–3686 (2012). https://doi.org/10.1200/JCO.2012.43.0116

    Article  Google Scholar 

  4. Ono, M., Ogilvie, J.M., Wilson, J.S., Green, H.J., Chambers, S.K., Ownsworth, T., Shum, D.H.K.: A meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer. Neuro-Oncology 5, 59 (2015). https://doi.org/10.3389/fonc.2015.00059

    Article  Google Scholar 

  5. Wefel, J.S., Schagen, S.B.: Chemotherapy-related cognitive dysfunction. Curr. Neurol. Neurosci. Rep. 12(3), 267–275 (2012). https://doi.org/10.1007/s11910-012-0264-9

    Article  Google Scholar 

  6. Ahles, T.A., Saykin, A.J., Furstenberg, C.T., Cole, B., Mott, L.A., Skalla, K., Whedon, M.B., Bivens, S., Mitchell, T., Greenberg, E.R., Silberfarb, P.M.: Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J. Clin. Oncol. Official J. Am. Soc. Clin. Oncol. 20(2), 485–493 (2002)

    Article  Google Scholar 

  7. Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., Verma, S.: Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psycho-Oncology 18(2), 134–143 (2009). https://doi.org/10.1002/pon.1379

    Article  Google Scholar 

  8. Yamada, T.H., Denburg, N.L., Beglinger, L.J., Schultz, S.K.: Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy. J. Neuropsychiatry Clin. Neurosci. 22(1), 48–54 (2010). https://doi.org/10.1176/appi.neuropsych.22.1.48

    Article  Google Scholar 

  9. Wefel, J.S., Saleeba, A.K., Buzdar, A.U., Meyers, C.A.: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116(14), 3348–3356 (2010). https://doi.org/10.1002/cncr.25098

    Article  Google Scholar 

  10. Wefel, J.S., Kesler, S.R., Noll, K.R., Schagen, S.B.: Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J. Clin. 65(2), 123–138 (2015). https://doi.org/10.3322/caac.21258

    Article  Google Scholar 

  11. Janelsins, M.C., Kesler, S.R., Ahles, T.A., Morrow, G.R.: Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int. Rev. Psychiatry 26(1), 102–113 (2014). http://doi.org/10.3109/09540261.2013.864260

    Article  Google Scholar 

  12. Jean-Pierre, P., Johnson-Greene, D., Burish, T.G.: Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development. Support. Care Cancer 22(8), 2251–2260 (2014). https://doi.org/10.1007/s00520-014-2162-y

    Article  Google Scholar 

  13. Hutchinson, A.D., Hosking, J.R., Kichenadasse, G., Mattiske, J.K., Wilson, C.: Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat. Rev. 38(7), 926–934 (2012). https://doi.org/10.1016/j.ctrv.2012.05.002

    Article  Google Scholar 

  14. Lai, J.-S., Wagner, L.I., Jacobsen, P.B., Cella, D.: Self-reported cognitive concerns and abilities: two sides of one coin? Psycho-Oncology 23(10), 1133–1141 (2014). https://doi.org/10.1002/pon.3522

    Article  Google Scholar 

  15. Wefel, J.S., Vardy, J., Ahles, T., Schagen, S.B.: International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 12(7), 703–708 (2011). https://doi.org/10.1016/S1470-2045(10)70294-1

    Article  Google Scholar 

  16. Jansen, C.E., Cooper, B.A., Dodd, M.J., Miaskowski, C.A.: A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support. Care Cancer 19(10), 1647–1656 (2011). https://doi.org/10.1007/s00520-010-0997-4

    Article  Google Scholar 

  17. Kaiser, J., Bledowski, C., Dietrich, J.: Neural correlates of chemotherapy-related cognitive impairment. Cortex 54, 33–50 (2014). https://doi.org/10.1016/j.cortex.2014.01.010

    Article  Google Scholar 

  18. van Dam, F.S., Schagen, S.B., Muller, M.J., Boogerd, W., Droogleever Fortuyn, M.E., Rodenhuis, S.: Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J. Natl. Cancer Inst. 90(3), 210–218 (1998)

    Article  Google Scholar 

  19. Wieneke, M.H., Dienst, E.R.: Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 4(1), 61–66 (1995). https://doi.org/10.1002/pon.2960040108

    Article  Google Scholar 

  20. Schagen, S.B., Boogerd, W., Muller, M.J., Huinink, W.T.B., Moonen, L., Meinhardt, W., Van Dam, F.S.: Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer (2008)

    Article  Google Scholar 

  21. Skaali, T., Fosså, S.D., Andersson, S., Cvancarova, M., Langberg, C.W., Lehne, G., Dahl, A.A.: Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress. J. Psychosom. Res. 70(5), 403–410 (2011). https://doi.org/10.1016/j.jpsychores.2010.12.004

    Article  Google Scholar 

  22. Weintraub, S., Dikmen, S.S., Heaton, R.K., Tulsky, D.S., Zelazo, P.D., Bauer, P.J., Carlozzi, N.E., Slotkin, J., Blitz, D., Wallner-Allen, K., Fox, N.A., Beaumont, J.L., Mungas, D., Nowinski, C.J., Richler, J., Deocampo, J.A., Anderson, J.E., Manly, J.J., Borosh, B., Havlik, R., Conway, K., Edwards, E., Freund, L., King, J.W., Moy, C., Witt, E., Gershon, R.C.: Cognition assessment using the NIH toolbox. Neurology, 80(11 Suppl 3), S54–S64 (2013). http://doi.org/10.1212/WNL.0b013e3182872ded

    Article  Google Scholar 

  23. Weintraub, S., Dikmen, S.S., Heaton, R.K., Tulsky, D.S., Zelazo, P.D., Slotkin, J.6., Carlozzi, N.E., Bauer, P.J., Wallner-Allen, K., Fox, N., Havlik, R., Beaumont, J.L., Mungas, D., Manly, J.J., Moy, C., Conway, K., Edwards, E., Nowinski, C.J., Gershon, R.: The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample. J. Int. Neuropsychol. Soc. JINS 20(6), 567–578 (2014). https://doi.org/10.1017/S1355617714000320

    Article  Google Scholar 

  24. Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., Cook, K., DeVellis, R., DeWalt, D., Fries, J.F., Gershon, R., Hahn, E.A., Lai, J.-S., Pilkonis, P, Revicki, D., Rose, M., Weinfurt, K., Hays, R.: Initial adult health item banks and first wave testing of the patient-reported outcomes measurement information system (PROMISTM) network: 2005–2008. J. Clin. Epidemiol. 63(11), 1179–1194 (2010). https://doi.org/10.1016/j.jclinepi.2010.04.011

  25. Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J.F., Bruce, B., Rose, M.: The patient-reported outcomes measurement information system (PROMIS). Med. Care 45(5 Suppl 1), S3–S11 (2007). http://doi.org/10.1097/01.mlr.0000258615.42478.55

    Article  Google Scholar 

  26. Riley, W.T., Rothrock, N., Bruce, B., Christodolou, C., Cook, K., Hahn, E.A., Cella, D.: Patient-reported outcomes measurement information system (PROMIS) domain names and definitions revisions: further evaluation of content validity in IRT-derived item banks. Qual. Life Res. Int. J. Qual. Life Aspects Treat. Care Rehabil. 19(9), 1311–1321 (2010). https://doi.org/10.1007/s11136-010-9694-5

    Article  Google Scholar 

  27. Cella, D., Lai, J.-S., Nowinski, C.J., Victorson, D., Peterman, A., Miller, D., Bethoux, F., Heinemann, A., Rubin, S., Cavazos, J.E., Reder, A.T., Sufit, R., Simuni, T., Holmes, G.L., Siderowf, A., Wojna, V., Bode, R., McKinney, N., Podrabsky, T., Wortman, K., Choi, S., Gershon, R., Rothrock, N., Moy, C.: Neuro-QOL brief measures of health-related quality of life for clinical research in neurology. Neurology 78(23), 1860–1867 (2012). http://doi.org/10.1212/WNL.0b013e318258f744

    Article  Google Scholar 

  28. O’Farrell, E., MacKenzie, J., Collins, B.: Clearing the Air: a review of our current understanding of “chemo fog”. Current Oncol. Rep. 15(3), 260–269 (2013). https://doi.org/10.1007/s11912-013-0307-7

    Article  Google Scholar 

  29. Parsey, C.M., Schmitter-Edgecombe, M.: Applications of technology in neuropsychological assessment. Clin. Neuropsychol. 27(8) (2013). http://doi.org/10.1080/13854046.2013.834971

    Article  Google Scholar 

  30. Zhang, L., Chai, X., Ling, S., Fan, J., Yang, K., Ren, Q.: Dispersion and accuracy of simulated phosphene positioning using tactile board. Artif. Organs 33(12), 1109–1116 (2009). https://doi.org/10.1111/j.1525-1594.2009.00826.x

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula Jacobs .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Jacobs, P., Anello, D., Elkin-Frankston, S. (2019). Using Design to Connect Patients, Providers, and Researchers: A Cognitive Assessment and Monitoring Platform for Integrative Research (CAMPFIRE). In: Lightner, N. (eds) Advances in Human Factors and Ergonomics in Healthcare and Medical Devices. AHFE 2018. Advances in Intelligent Systems and Computing, vol 779. Springer, Cham. https://doi.org/10.1007/978-3-319-94373-2_1

Download citation

Publish with us

Policies and ethics